GL1X · GenesisL1 explorer

MolNFT v1 · #47948 · protein

Structure of human hyaluronidase 1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis

2PE4 · Hyaluronidase-1: “Structure of human hyaluronidase 1, a hyaluronan hydrolyzing enzyme involved in tumor growth and angiogenesis”. X-ray diffraction, 3 ligands (NAG, MAN, BMA), 4 pockets (best druggability 0.58). MolNFT v1 #47948 on…

PDB
2PE4
Type
protein
Length
417 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hyaluronidase-1
EC
3.2.1.35
UniProt
Q12794
Ligands
NAG, MAN, BMA
Pockets
4 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHyaluronidase-1 (EC 3.2.1.35)protein41741% helix, 15% strandQ12794

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains A
  • MAN · alpha-D-mannopyranose · sugar · 3 copies
  • BMA · beta-D-mannopyranose · sugar
  • ACT · Acetate ion · additive · 7 copies · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12170.580.7935ACT
21110.480.8020empty
3610.390.8015empty
4860.300.7218empty

Modifications

Observed in the structure: 5 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 2PE4 · Structure of Human Hyaluronidase 1, a Hyaluronan Hydrolyzing Enzyme Involved in Tumor… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q12794 · AlphaFold monomer V2.0 prediction for hyaluronidase-1 (Q12794) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.